MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K.
Right arrow Articles by Igarashi, K.

Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit

K Williams, J Chao, K Kashiwagi, T Masuko and K Igarashi

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084, USA.

Glutamate and glycine are coagonists that act at distinct sites to activate N-methyl-D-aspartate (NMDA) receptors. In the NR1 subunit of the NMDA receptor, mutation of D732 to glutamate (D732E), asparagine (D732N), alanine (D732A), or glycine (D732G) reduced the potency of glycine by > 4000-fold, but these mutations had no effect on sensitivity to glutamate. Mutations at NR1(D732) also changed sensitivity to the glycine-site agonists D-serine and D-alanine, reducing the potencies and, in some cases, the efficacies of these compounds. Thus, D-serine was a full agonist at the glycine site of receptors containing NR1(D732N) and NR1(D732A), a partial agonist at receptors containing NR1(D732G), and a competitive antagonist at receptors containing NR1(D732). Mutations at NR1(D732) had no effect or produced an increase in sensitivity to the glycine-site antagonists 6,7- dichloroquinoxaline-2,3-dione and 5,7-dichlorokynurenic acid. These mutations did not affect the reversal potential, voltage-dependent block by extracellular Mg2+, block by ifenprodil, or stimulation by spermine at NR1/NR2B receptors. NR2 subunits containing mutations at NR2A(D731) and NR2B(D732), which correspond to NR1(D732), did not produce functional receptors when coexpressed with NR1. Residue D732 in NR1 may be close to a glycine binding site on the NMDA receptor and may directly affect the properties of this site or be critical for coupling of glycine binding to channel activation.

Volume 50, Issue 4, pp. 701-708, 10/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Physiol.Home page
P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al.
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes
J. Physiol., January 1, 2008; 586(1): 227 - 245.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Awobuluyi, J. Yang, Y. Ye, J. E. Chatterton, A. Godzik, S. A. Lipton, and D. Zhang
Subunit-Specific Roles of Glycine-Binding Domains in Activation of NR1/NR3 N-Methyl-D-aspartate Receptors
Mol. Pharmacol., January 1, 2007; 71(1): 112 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen
Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit
J. Physiol., July 15, 2006; 574(2): 477 - 489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne
Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis
Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. E. Chen, M. T. Geballe, P. J. Stansfeld, A. R. Johnston, H. Yuan, A. L. Jacob, J. P. Snyder, S. F. Traynelis, and D. J. A. Wyllie
Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling
Mol. Pharmacol., May 1, 2005; 67(5): 1470 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Hu, L. Zhang, R. R. Stewart, and F. F. Weight
Arginine 222 in the Pre-transmembrane Domain 1 of 5-HT3A Receptors Links Agonist Binding to Channel Gating
J. Biol. Chem., November 21, 2003; 278(47): 46583 - 46589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Foucaud, B. Laube, R. Schemm, A. Kreimeyer, M. Goeldner, and H. Betz
Structural Model of the N-Methyl-D-aspartate Receptor Glycine Site Probed by Site-directed Chemical Coupling
J. Biol. Chem., June 20, 2003; 278(26): 24011 - 24017.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H.-T. Liu, M. W. Hollmann, W.-H. Liu, C. W. Hoenemann, and M. E. Durieux
Modulation of NMDA Receptor Function by Ketamine and Magnesium: Part I
Anesth. Analg., May 1, 2001; 92(5): 1173 - 1181.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-P. Mothet, A. T. Parent, H. Wolosker, R. O. Brady Jr., D. J. Linden, C. D. Ferris, M. A. Rogawski, and S. H. Snyder
D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
PNAS, April 25, 2000; 97(9): 4926 - 4931.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Honer, D. Benke, B. Laube, J. Kuhse, R. Heckendorn, H. Allgeier, C. Angst, H. Monyer, P. H. Seeburg, H. Betz, et al.
Differentiation of Glycine Antagonist Sites of N-Methyl-D-aspartate Receptor Subtypes. PREFERENTIAL INTERACTION OF CGP 61594 WITH NR1/2B RECEPTORS
J. Biol. Chem., May 1, 1998; 273(18): 11158 - 11163.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. C. Anson, P. E. Chen, D. J. A. Wyllie, D. Colquhoun, and R. Schoepfer
Identification of Amino Acid Residues of the NR2A Subunit That Control Glutamate Potency in Recombinant NR1/NR2A NMDA Receptors
J. Neurosci., January 15, 1998; 18(2): 581 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. W. Wood, H. M.A. VanDongen, and A. M.J. VanDongen
An Alanine Residue in the M3-M4 Linker Lines the Glycine Binding Pocket of the N-Methyl-D-aspartate Receptor
J. Biol. Chem., February 7, 1997; 272(6): 3532 - 3537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Abele, K. Keinanen, and D. R. Madden
Agonist-induced Isomerization in a Glutamate Receptor Ligand-binding Domain. A KINETIC AND MUTAGENETIC ANALYSIS
J. Biol. Chem., July 7, 2000; 275(28): 21355 - 21363.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics